{
    "clinical_study": {
        "@rank": "3440", 
        "brief_summary": {
            "textblock": "This is a non-randomized study in patients who have received prior 5-FU therapy for\n      colorectal cancer. The objective of this trial is to establish a maximum tolerated dose of\n      ALIMTA and irinotecan given in combination as well as to assess the safety and efficacy of\n      this combination for patients with locally advanced or metastatic colorectal cancer. ALIMTA\n      and irinotecan will be given every 21 days."
        }, 
        "brief_title": "A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.", 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologic or cytologic diagnosis of locally or metastatic colorectal cancer\n\n          -  Prior therapy with 5-FU for metastatic cancer\n\n          -  Adequate bone marrow, liver and kidney function\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Breast feeding\n\n          -  Inability to interrupt aspirin therapy\n\n          -  Brain metastasis\n\n          -  Patients who have been treated previously with ALIMTA or irinotecan"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "April 29, 2002", 
        "id_info": {
            "nct_id": "NCT00034502", 
            "org_study_id": "2927", 
            "secondary_id": "H3E-MC-JMDO"
        }, 
        "intervention": [
            {
                "intervention_name": "ALIMTA", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "irinotecan", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Irinotecan", 
                "Pemetrexed"
            ]
        }, 
        "lastchanged_date": "July 18, 2006", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bielefeld", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halle", 
                        "country": "Germany"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Homburg/Saar", 
                        "country": "Germany"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munchen", 
                        "country": "Germany"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany"
            ]
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1/Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00034502"
        }, 
        "source": "Eli Lilly and Company", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eli Lilly and Company", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2006"
    }, 
    "geocoordinates": {
        "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.": "48.145 11.558"
    }
}